These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 11931394)
1. Another step on the path to better TB therapies. Vernon A; Burman W; Horsburgh CR Int J Tuberc Lung Dis; 2002 Jan; 6(1):1-2. PubMed ID: 11931394 [No Abstract] [Full Text] [Related]
2. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection. Stout JE Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147 [TBL] [Abstract][Full Text] [Related]
3. Rifapentine and isoniazid in the continuation phase of a 6-month regimen. Final report at 5 years: prognostic value of various measures. Tam CM; Chan SL; Kam KM; Goodall RL; Mitchison DA Int J Tuberc Lung Dis; 2002 Jan; 6(1):3-10. PubMed ID: 11931398 [TBL] [Abstract][Full Text] [Related]
4. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis. Gao XF; Wang L; Liu GJ; Wen J; Sun X; Xie Y; Li YP Int J Tuberc Lung Dis; 2006 Oct; 10(10):1080-90. PubMed ID: 17044199 [TBL] [Abstract][Full Text] [Related]
5. Treatment of childhood tuberculosis. Indian Pediatr; 1998 Aug; 35(8):816-9. PubMed ID: 10216589 [No Abstract] [Full Text] [Related]
7. Drug-resistance tuberculosis among the foreign-born in Canada. Can Commun Dis Rep; 2005 Feb; 31(4):46-52. PubMed ID: 15712449 [No Abstract] [Full Text] [Related]
8. [Tuberculosis of the middle ear: a rare extrapulmonary manifestation]. Schütte W; Berghaus A; Schütte A Dtsch Med Wochenschr; 1996 Dec; 121(49):1551. PubMed ID: 8998926 [No Abstract] [Full Text] [Related]
9. [Drug-resistant pulmonary tuberculosis at the penitentiaries]. Kononets AS Probl Tuberk Bolezn Legk; 2008; (12):60-3. PubMed ID: 19227326 [TBL] [Abstract][Full Text] [Related]
10. Modern methods for assessing the drugs used in the chemotherapy of mycobacterial disease. Mitchison DA Soc Appl Bacteriol Symp Ser; 1996; 25():72S-80S. PubMed ID: 8972122 [No Abstract] [Full Text] [Related]
11. [Intradermal reaction to tuberculin: application, interpretation and therapeutic implications]. Van Vooren JP Rev Med Brux; 2000 Feb; 21(1):A45-8. PubMed ID: 10748688 [No Abstract] [Full Text] [Related]
12. Clinical trial of rifampicin in the treatment of pulmonary tuberculosis in Lagos. Makanjuola OO Niger Med J; 1973 Jul; 3(3):156-7. PubMed ID: 16366352 [No Abstract] [Full Text] [Related]
13. Delayed death from pulmonary tuberculosis: unsuspected subtherapeutic drug levels. Morehead RS South Med J; 2000 May; 93(5):507-10. PubMed ID: 10832953 [TBL] [Abstract][Full Text] [Related]
14. Phenomenon of rifampicin-induced discolouration of body fluids. Morgan JR; Clarke KW; Brear SG Respir Med; 1993 May; 87(4):320-1. PubMed ID: 9728237 [No Abstract] [Full Text] [Related]
15. Moving forward with evidence and controversies: the challenges of MDR-TB. Chiang CY; Van Deun A; Caminero JA Int J Tuberc Lung Dis; 2006 Aug; 10(8):827. PubMed ID: 16898363 [No Abstract] [Full Text] [Related]
16. New TB drug approved. AIDS Patient Care; 1995 Feb; 9(1):42. PubMed ID: 11361363 [No Abstract] [Full Text] [Related]